bpc 157 huberman Origins & Effects of BPC-157 | Dr. Abud Bakri & Dr. Andrew Andrew Huberman consults an expert

Protocol approach 3: comprehensive repair (thymosin alpha-1 plus BPC-157 plus TB-500) Goal: Immune rebalancing combined with aggressive tissue repair Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week BPC-157: 250 mcg subcutaneously twice daily near affected tissue TB-500 : 2-5 mg subcutaneously twice per week for loading, then weekly for maintenance Rationale: This three-peptide approach targets immune regulation (TA1), mucosal and tissue healing (BPC-157), and cellular migration plus repair (TB-500)

Quick checkout guest or account

This blend combines both peptides for synergistic tissue-repair research applications

Tendon studies often report changes in tensile strength, collagen alignment, and cellular infiltration

As research continues, we expect to see these protocols refined and perhaps even integrated into standard care